20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica Advisor to Riverside for AlterPharma
Firsthand strategies from portfolio company CEO’s who outperformed in uncertain times Portfolio company leaders are facing bigger challenges than ever before. Unprecedented macro-headwinds from increased…
Read more
Zurich, 10 July 2025 – Humatica posted further growth in the first half of 2025, topping record same-period growth last year. Consulting fee revenues increased…
Read more
Accelerating behavioral change to improve business performance GloCoach, the global leader in AI-enabled leadership development and coaching, and Humatica, the leading advisor in organizational effectiveness…
Read more
